# Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer

> **NCT06728150** · — · NOT_YET_RECRUITING · sponsor: **Monash University** · enrollment: 45 (estimated)

## Conditions studied

- Breast Cancer Metastatic
- Brain Metastasases

## Interventions

- **RADIATION:** computerized tomography

## Key facts

- **NCT ID:** NCT06728150
- **Lead sponsor:** Monash University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-12-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06728150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06728150, "Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06728150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*